A family history of prostate cancer can raise a man’s risk and can justify starting PSA screening earlier than someone at average risk. Risk is greatest when a father or brother was diagnosed young, when several close relatives have prostate cancer, or when a relative developed metastatic disease or died from it. A family history changes the screening plan, but it does not mean that prostate cancer is inevitable or that one lower PSA cutoff automatically applies to every man.
01. How Much Does Family History Increase Prostate Cancer Risk?
Does having a father or brother with prostate cancer increase risk?
Yes.
A first-degree relative with prostate cancer is one of the best-established risk factors for developing the disease.
First-degree relatives include:
- a father;
- a brother;
- and a son.
The National Cancer Institute summarizes pooled research showing that one affected first-degree relative is associated with roughly 2.5 times the relative risk of prostate cancer compared with men without that family history.
The magnitude varies with the relationship, number of affected relatives and age at diagnosis.
Is risk higher if a brother had prostate cancer than if a father had it?
In pooled studies summarized by the National Cancer Institute, having an affected brother was associated with a higher relative-risk estimate than having an affected father.
The pooled values were approximately:
- 3.14 for an affected brother;
- and 2.35 for an affected father.
These estimates should not be interpreted as a biological rule that a brother’s diagnosis is always more important.
The relative’s age at diagnosis, number of other affected relatives and aggressiveness of the cancer can matter more than the relationship alone.
Does age at diagnosis in the family matter?
Yes.
Earlier prostate cancer in a close relative generally raises greater concern for inherited susceptibility.
The NCI meta-analysis found a pooled relative risk of approximately:
- 2.87 when a first-degree relative was diagnosed before age 65;
- compared with approximately 1.92 when the affected first-degree relative was diagnosed at age 65 or older.
Current urology screening guidelines therefore pay particular attention to prostate cancer occurring before ages 60–65.
02. Which Family-History Patterns Matter Most?
What counts as a strong family history of prostate cancer?
There is no single universally accepted definition.
Current AUA/SUO guidance notes that commonly used definitions of strong family history include a person with:
- a father or brother with prostate cancer diagnosed before age 60;
- a father or brother who died from prostate cancer;
- a father or brother who developed metastatic prostate cancer;
- or two or more male relatives with one of those patterns.
The family history becomes more concerning as these features accumulate.
Does prostate cancer on the mother’s side count?
Yes.
Inherited cancer-risk variants can be passed through either the maternal or paternal side of the family.
A maternal grandfather or maternal uncle with aggressive or early prostate cancer can therefore contribute meaningful information even though they are not first-degree relatives.
The same principle applies when a mother’s side of the family contains breast, ovarian, pancreatic or certain colorectal cancers suggestive of an inherited cancer syndrome.
Can cancers in female relatives matter for a man’s prostate cancer risk?
Yes.
A prostate-cancer family history should not be limited to male relatives.
Families carrying pathogenic variants such as BRCA2 can show combinations of:
- prostate cancer;
- breast cancer;
- male breast cancer;
- ovarian cancer;
- and pancreatic cancer.
Lynch syndrome can create another pattern involving cancers such as:
- colorectal cancer;
- endometrial cancer;
- and several other Lynch-associated cancers.
Current AUA guidance therefore includes some multi-cancer family patterns when considering whether a family history is strongly suggestive of inherited prostate-cancer risk.
What is the difference between familial and hereditary prostate cancer?
The terms overlap but are not identical.
Familial prostate cancer means prostate cancer clusters in a family more than expected.
This can reflect:
- shared inherited variants;
- shared environmental factors;
- chance;
- or a combination of these.
Hereditary prostate cancer implies a stronger inherited predisposition, sometimes associated with a pathogenic germline variant.
Not every family with several prostate cancers will have an identifiable mutation.
When should genetic counseling or germline testing be considered?
A particularly strong family pattern may justify cancer-genetics assessment.
Current EAU guidance recommends considering germline testing when there are:
- multiple family members with prostate cancer diagnosed before age 60;
- a family member who died from prostate cancer before age 60;
- a known high-risk inherited mutation in the family;
- or multiple related cancers occurring on the same side of the family.
Genetic counseling is important because testing can have implications not only for the person being tested but also for siblings, children and other relatives.
03. When Should PSA Screening Start With a Family History of Prostate Cancer?
Should men with a family history start screening at age 40?
Some should, but not every man with any family history needs to start at exactly 40.
The most appropriate starting point depends on the strength of the family pattern.
| Family-risk pattern | Current screening approach | Why |
|---|---|---|
| One older relative with prostate cancer | Individualize according to relationship, age at diagnosis and other risks. | Family history is relevant, but the inherited signal may be modest. |
| Strong family history | AUA/SUO: offer screening from approximately 40–45. | Higher probability of clinically significant or earlier-onset disease. |
| Family history with prostate cancer before age 60 | EAU: offer early PSA testing from approximately 45. | Younger diagnosis in the family increases concern for inherited risk. |
| Father or brother diagnosed before age 65 | ACS: discuss screening from approximately 45. | First-degree early prostate cancer places the man in a higher-risk group. |
| More than one first-degree relative diagnosed early | ACS: discuss screening from approximately 40. | Multiple affected close relatives indicate an even higher-risk family pattern. |
| Known BRCA2 mutation | EAU: early PSA testing from approximately 40. | BRCA2 is associated with increased prostate-cancer risk and clinically important disease. |
For the broader comparison of screening ages across risk groups, see When Should Men Start Prostate Cancer Screening?.
Does family history mean PSA should be tested every year?
Not automatically.
Current AUA/SUO guidance states that people at increased risk may need both an earlier start and a shorter re-screening interval.
However, the interval after the first test can still be personalized using:
- the baseline PSA;
- age;
- strength of family history;
- known inherited mutations;
- overall health;
- and previous PSA results.
A 42-year-old with three relatives who developed aggressive prostate cancer in their 50s may reasonably be followed differently from a 55-year-old whose only affected relative was diagnosed with low-risk disease in his 80s.
Does a normal first PSA eliminate inherited risk?
No.
A low baseline PSA can be reassuring for near-term risk, but it does not erase a strong family history.
Family history remains relevant when deciding how long the interval should be before the next PSA.
This is particularly important when several close relatives had aggressive or early-onset disease.
04. How Does Family History Change What Happens After a PSA Test?
Does family history change what PSA level is considered normal?
Family history changes the risk interpretation of a PSA result, but it does not create one universally accepted “family-history PSA cutoff.”
For example, the same PSA concentration can imply different overall probabilities of clinically significant cancer in two men with different:
- ages;
- prostate volumes;
- family histories;
- examination findings;
- genetic risks;
- and MRI findings.
This is why a PSA result should not be interpreted from the number alone.
What happens if PSA is elevated in a man with a strong family history?
A family history increases the pre-test probability that a persistent PSA elevation may represent clinically important disease.
It does not mean the first abnormal PSA should lead directly to biopsy.
Current AUA/SUO guidance recommends repeating a newly elevated PSA before moving directly to secondary biomarkers, imaging or biopsy.
If PSA remains elevated, assessment can combine:
- family history;
- age;
- digital rectal examination;
- percent-free PSA or another biomarker;
- prostate volume;
- PSA density;
- validated risk calculators;
- and prostate MRI.
Family history is included in several contemporary prostate-cancer risk calculators because it changes the probability associated with the PSA result.
Does a high PSA with family history mean prostate cancer is likely?
It means the combination deserves careful evaluation, but neither factor proves cancer.
PSA can also rise because of:
- benign prostate enlargement;
- prostatitis or urinary infection;
- urinary retention;
- recent ejaculation;
- recent prostate procedures;
- and normal biological variation.
This is why PSA can be high without prostate cancer even in someone who has a strong family history.
Can a low PSA completely rule out cancer in a high-risk family?
No.
A low PSA generally lowers near-term concern, but no PSA value completely excludes prostate cancer.
The screening interval can therefore remain shorter in some high-risk families even when the baseline PSA is reassuring.
Should PSA velocity be used because the man has a family history?
A PSA trend can provide context, but family history does not make PSA velocity a stand-alone biopsy test.
Current AUA/SUO guidance recommends against using PSA velocity as the sole reason for secondary biomarkers, MRI or biopsy.
Family history, PSA level, examination, prostate volume and imaging should be interpreted together.
Family History and PSA Screening at a Glance
| Question | Practical answer |
|---|---|
| Does family history increase prostate-cancer risk? | Yes. |
| How much does one affected first-degree relative increase risk? | NCI-pooled data estimate roughly 2.5-fold relative risk overall. |
| What is the pooled risk with an affected father? | Approximately 2.35 times the comparison-group risk. |
| What is the pooled risk with an affected brother? | Approximately 3.14 times. |
| What about two or more affected first-degree relatives? | Approximately 4.39 times in the NCI-summarized meta-analysis. |
| Does a younger diagnosis in the family matter? | Yes. Early-onset disease is associated with greater familial risk. |
| What relationships are first-degree? | Father, brother and son. |
| Does the mother’s side count? | Yes. Cancer-risk variants can be inherited through either parent. |
| Does a maternal grandfather’s prostate cancer matter? | Potentially, especially when diagnosis was young, aggressive or part of a larger cancer pattern. |
| Can breast or ovarian cancer in the family matter? | Yes. It may indicate an inherited syndrome such as a BRCA-associated cancer pattern. |
| What counts as a strong family history? | Common criteria include early prostate cancer in a father or brother, metastatic or lethal prostate cancer in close relatives, or several affected male relatives. |
| When does AUA/SUO recommend screening with strong family history? | Offer PSA screening from approximately age 40–45. |
| What does EAU recommend? | Offer early PSA testing from age 45 when prostate cancer occurred in the family before age 60. |
| What does ACS recommend with one early affected father or brother? | Discuss screening from age 45 when the first-degree relative was diagnosed before age 65. |
| What if more than one first-degree relative was diagnosed young? | ACS recommends beginning the discussion around age 40. |
| Does every family-history patient need annual PSA? | No. Interval should be personalized using PSA, age and the strength of inherited risk. |
| Does a low baseline PSA eliminate inherited risk? | No. |
| Does family history create one lower PSA cutoff? | No. It changes overall cancer probability rather than creating one universal threshold. |
| Should an elevated PSA go directly to biopsy? | Usually no. A newly elevated PSA is generally repeated first. |
| Can family history be used in prostate-cancer risk calculators? | Yes. Several validated tools include family history as a risk variable. |
| Can genetic testing be appropriate? | Yes, in selected families with multiple early prostate cancers, lethal disease, known high-risk mutations or related cancers. |
Summary
- Family history is an established prostate-cancer risk factor.
- One affected first-degree relative approximately doubles to triples relative risk in pooled studies.
- NCI-summarized evidence estimates a relative risk of approximately 2.35 when a father is affected.
- The pooled estimate is approximately 3.14 when a brother is affected.
- One affected first-degree relative is associated with an overall pooled relative risk of approximately 2.48.
- Two or more affected first-degree relatives are associated with a substantially greater pooled relative risk of approximately 4.39.
- These figures are relative risks, not an individual’s absolute probability of cancer.
- Family risk is generally greater when relatives developed prostate cancer at younger ages.
- Several affected relatives are more concerning than one isolated late-life diagnosis.
- Metastatic or lethal prostate cancer in a close relative strengthens the family-history signal.
- Both the maternal and paternal sides of the family matter.
- Patterns of breast, ovarian, pancreatic or other inherited-syndrome cancers can also be relevant.
- Familial prostate cancer does not always mean an identifiable genetic mutation is present.
- Strong hereditary patterns may justify genetic counseling and possible germline testing.
- Current AUA/SUO guidance recommends offering PSA screening from ages 40–45 for people with a strong family history.
- Current EAU guidance recommends early PSA testing from age 45 for men with a family history of prostate cancer diagnosed before age 60.
- The American Cancer Society recommends discussing screening at age 45 when a father or brother developed prostate cancer before age 65.
- ACS moves the discussion to age 40 when more than one first-degree relative had early prostate cancer.
- A family history does not create one universal PSA cutoff.
- The first PSA level can help determine future screening frequency.
- A reassuring PSA does not erase inherited risk.
- A newly elevated PSA should generally be confirmed before proceeding directly to imaging or biopsy.
- Family history is considered together with age, PSA, examination, prostate volume, PSA density, biomarkers and MRI.
- Family history raises prostate-cancer probability; it does not diagnose prostate cancer.
Educational disclaimer: This article provides general medical education about prostate-cancer family history and PSA screening. Family structures and inherited cancer patterns can be complex, and relative-risk estimates from population studies cannot calculate an individual’s exact cancer probability. Screening age, testing interval, genetic counseling and further investigation should be individualized according to the detailed family history, PSA results, ancestry, known genetic variants, overall health and life expectancy.
Explore the PSA Pathway
For the overall PSA testing framework, see PSA Testing and Prostate Screening.
For the broader age-based screening discussion, see When Should Men Start Prostate Cancer Screening?.
For what the screening biomarker measures, see What Is PSA?.
For interpreting PSA by age rather than family history alone, see PSA Levels by Age.
For PSA relative to prostate volume, see What Is PSA Density?.
For why an elevated result does not automatically establish cancer, see Can PSA Be High Without Prostate Cancer?.
The next guide explains what happens after a high PSA, when the blood test should be repeated and how MRI, biomarkers and biopsy are used when the elevation persists.
Evidence Sources
- American Urological Association / Society of Urologic Oncology. Early Detection of Prostate Cancer Guideline Part I — Screening, Strong Family History and Increased-Risk Starting Ages.
- Updates to Early Detection of Prostate Cancer: AUA/SUO Guideline. Journal of Urology. 2026.
- European Association of Urology. Prostate Cancer Guidelines — Individual Early Detection, Family History, BRCA2 and Germline Testing.
- National Cancer Institute. Genetics of Prostate Cancer — Family-History Relative Risks and Hereditary Cancer Patterns.
- American Cancer Society. Recommendations for Prostate Cancer Early Detection — Screening Ages for Family-History Risk.
- American Cancer Society. Prostate Cancer Risk Factors — Family History and Inherited Gene Changes.
